Clinical outcome after laparoscopic Nissen fundoplication in patients with GERD and PPI refractory heartburn.


Journal

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus
ISSN: 1442-2050
Titre abrégé: Dis Esophagus
Pays: United States
ID NLM: 8809160

Informations de publication

Date de publication:
15 Apr 2020
Historique:
received: 07 10 2019
revised: 19 11 2019
accepted: 07 10 2019
pubmed: 17 1 2020
medline: 23 1 2021
entrez: 17 1 2020
Statut: ppublish

Résumé

Typical reflux symptoms that respond well to proton pump inhibitor (PPI) therapy are key factors predictive of an excellent outcome with antireflux surgery for gastroesophageal reflux disease (GERD). Our aim was to evaluate whether poor preoperative heartburn (HB) relief with PPIs was associated with a worse outcome after Nissen fundoplication. Patients with a main symptom of HB and a positive pH-test who had a laparoscopic Nissen fundoplication between January 2008 and December 2014 were included. Prior to surgery, patients graded how effectively their HB symptoms were relieved by PPIs. Three groups were defined: good response (76-100% relief), partial response (26-75% relief) and poor response (0-25% relief). Outcomes and satisfaction were assessed at a minimum of 1 year after fundoplication. There were 129 patients who met inclusion criteria and 75 agreed to participate. The median follow-up was 48 months. Prior to Nissen fundoplication 13 patients had a good HB response to PPI-therapy, 36 had a partial response and 26 had a poor response. All patients were satisfied with their HB relief after fundoplication (mean satisfaction score: 9.5/10) and there was no difference in satisfaction score or heartburn relief between groups. Heartburn symptoms that respond poorly to PPI therapy are reliably relieved with a Nissen fundoplication in patients with objectively confirmed GERD. Patient satisfaction after Nissen fundoplication was excellent and was similar in patients with poor versus excellent HB relief with preoperative PPI therapy. Therefore, antireflux surgery is an option for patients with HB and confirmed GERD regardless of the degree of relief of HB symptoms provided by PPI medications.

Identifiants

pubmed: 31942976
pii: 5706866
doi: 10.1093/dote/doz099
pii:
doi:

Substances chimiques

Proton Pump Inhibitors 0

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Katrin Schwameis (K)

Division of Thoracic Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

Daniel Oh (D)

Division of Thoracic Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

Kyle M Green (KM)

Division of Thoracic Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

Brenda Lin (B)

Division of Thoracic Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

Jörg Zehetner (J)

Department of Surgery, Klinik Beau-Site Hirslanden Bern, Bern, Switzerland.

John C Lipham (JC)

Division of General Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

Jeffrey A Hagen (JA)

Division of Thoracic Surgery, Sanger Heart and Vascular Institute, Charlotte, NC, USA.
Thoracic, Surgical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.

Steven R DeMeester (SR)

Division of Foregut and Minimally Invasive Surgery, The Oregon Clinic, Portland, OR, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH